Know Cancer

or
forgot password

The Role of Tomotherapy (Dynamic IMRT and Megavoltage CT Scanning) in Hypofractionated/Dose Escalated Conformal Radiation Treatment Using Magnetic Resonance Spectroscopy (MRS) Scans to Predict and Document the Pattern of Local Failure for High Risk Prostate Cancer


Phase 1/Phase 2
N/A
75 Years
Open (Enrolling)
Male
Prostate Cancer

Thank you

Trial Information

The Role of Tomotherapy (Dynamic IMRT and Megavoltage CT Scanning) in Hypofractionated/Dose Escalated Conformal Radiation Treatment Using Magnetic Resonance Spectroscopy (MRS) Scans to Predict and Document the Pattern of Local Failure for High Risk Prostate Cancer


Inclusion Criteria:



- High risk localized prostate cancer

Exclusion Criteria:

- Low/intermediate risk, metastatic cancer

- Patient refusal

Type of Study:

Interventional

Study Design:

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Rectal Toxicity

Outcome Description:

Determine the acute and late rectal toxicity of high-dose short-course hypofractionated radiotherapy in five weeks in the treatment of high rish prostate cancer.

Outcome Time Frame:

5 weeks

Safety Issue:

Yes

Principal Investigator

Robert Pearcey, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Alberta Health Services

Authority:

Canada: Health Canada

Study ID:

GU-06-0052/ethics 21781

NCT ID:

NCT00126802

Start Date:

April 2005

Completion Date:

March 2013

Related Keywords:

  • Prostate Cancer
  • tomotherapy
  • MRSZ
  • high risk prostate cancer
  • Prostatic Neoplasms

Name

Location